2m 2m 2m 2m 2m 2m 2m
Enlivex (ENLV)
NASDAQ
$1.54+$0.07 (+4.69%)
Price as of Aug 21, 2026 7:59 PM EDT- $349.0MMarket Cap
- -90.67%1-Year Change
- BiotechnologyIndustry
Enlivex (ENLV)
$1.54+$0.07 (+4.69%)
ENLV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.47 | ||
Change | -$0.03 (-2.00%) | ||
Open | $1.49 | ||
High | $1.52 | ||
Low | $1.39 | ||
Previous Close | $1.50 | ||
Volume | 157,528 | ||
30-Day Average Volume | 422,849 | ||
1-Week Change | -6.96% | ||
1-Month Change | -68.92% | ||
1-Year Change | -90.67% | ||
3-Year Change | -96.13% | ||
5-Year Change | -99.05% | ||
Fundamentals | |||
Shares Outstanding | 237.4M | ||
Total Assets | $2.3B | ||
Market Cap | $349.0M | ||
Enterprise Value | $347.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 07/09/2026 | ||
Earnings & Revenue